ACM
CRDF icon

Altium Capital Management’s Cardiff Oncology CRDF Stock Holding History

Altium Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-337,000
Closed -$2.02M – 127
2021
Q4 		$2.02M Sell
337,000
-11,888
-3% -$70.9K 0.56% 64
2021
Q3 		$2.32M Sell
348,888
-152,990
-30% -$961K 0.61% 67
2021
Q2 		$3.34M Buy
+501,878
New +$4.26M 0.77% 55
2021
Q1 		– Sell
-185,552
Closed -$3.34M – 130
2020
Q4 		$3.34M Buy
+185,552
New +$3.26M 1.25% 31

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Altium Capital Management's CRDF Position: Q1 2022 in Review

Altium Capital Management sold out of Cardiff Oncology (CRDF) in Q1 2022, closing a stake of 337,000 shares — an estimated $2.02M sold.

Altium Capital Management first reported a position in CRDF in Q4 2020 and held it in 4 quarters. The position peaked at $3.34M in Q4 2020. 91 funds tracked by Wall St. Rank hold CRDF as of Q1 2022.

  • Altium Capital Management reported no remaining Cardiff Oncology position as of Q1 2022 after selling out during the quarter.
  • Altium Capital Management sold 337,000 Cardiff Oncology shares in Q1 2022, an estimated $2.02M.
  • Altium Capital Management first reported a position in Cardiff Oncology in Q4 2020 and held it in 4 quarters.
  • Altium Capital Management's Cardiff Oncology position peaked at $3.34M in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2022.

Based on Altium Capital Management's 13F filing for Q1 2022, filed 16 May 2022.